Literature DB >> 21892143

Wnt: what's needed to maintain pluripotency?

Hitoshi Niwa.   

Abstract

A precise role for the canonical Wnt pathway in maintaining pluripotency in mouse embryonic stem cells (mESCs) has been debated. Four recent reports add pieces to the puzzle and together these results may help establish a robust model.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21892143     DOI： 10.1038/ncb2333

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


  16 in total

1.  Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.

Authors:  Bradley W Doble; Satish Patel; Geoffrey A Wood; Lisa K Kockeritz; James R Woodgett
Journal:  Dev Cell       Date:  2007-06       Impact factor: 12.270

2.  Metastable pluripotent states in NOD-mouse-derived ESCs.

Authors:  Jacob Hanna; Styliani Markoulaki; Maisam Mitalipova; Albert W Cheng; John P Cassady; Judith Staerk; Bryce W Carey; Christopher J Lengner; Ruth Foreman; Jennifer Love; Qing Gao; Jongpil Kim; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-05-07       Impact factor: 24.633

3.  Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells.

Authors:  Derk ten Berge; Dorota Kurek; Tim Blauwkamp; Wouter Koole; Alex Maas; Elif Eroglu; Ronald K Siu; Roel Nusse
Journal:  Nat Cell Biol       Date:  2011-08-14       Impact factor: 28.824

4.  Beta-catenin signaling contributes to stemness and regulates early differentiation in murine embryonic stem cells.

Authors:  Roman Anton; Hans A Kestler; Michael Kühl
Journal:  FEBS Lett       Date:  2007-10-15       Impact factor: 4.124

5.  Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells.

Authors:  Alexander Marson; Stuart S Levine; Megan F Cole; Garrett M Frampton; Tobias Brambrink; Sarah Johnstone; Matthew G Guenther; Wendy K Johnston; Marius Wernig; Jamie Newman; J Mauro Calabrese; Lucas M Dennis; Thomas L Volkert; Sumeet Gupta; Jennifer Love; Nancy Hannett; Phillip A Sharp; David P Bartel; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2008-08-08       Impact factor: 41.582

6.  Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal.

Authors:  Fei Yi; Laura Pereira; Bradley James Merrill
Journal:  Stem Cells       Date:  2008-05-15       Impact factor: 6.277

7.  T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways.

Authors:  Wai-Leong Tam; Chin Yan Lim; Jianyong Han; Jinqiu Zhang; Yen-Sin Ang; Huck-Hui Ng; Henry Yang; Bing Lim
Journal:  Stem Cells       Date:  2008-05-08       Impact factor: 6.277

8.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.

Authors:  Noboru Sato; Laurent Meijer; Leandros Skaltsounis; Paul Greengard; Ali H Brivanlou
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

9.  Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation.

Authors:  Jason Wray; Tüzer Kalkan; Sandra Gomez-Lopez; Dominik Eckardt; Andrew Cook; Rolf Kemler; Austin Smith
Journal:  Nat Cell Biol       Date:  2011-06-19       Impact factor: 28.824

10.  Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation.

Authors:  Natalia Lyashenko; Markus Winter; Domenico Migliorini; Travis Biechele; Randall T Moon; Christine Hartmann
Journal:  Nat Cell Biol       Date:  2011-06-19       Impact factor: 28.824
View more
  21 in total

Review 1.  Mitotic and mitogenic Wnt signalling.

Authors:  Christof Niehrs; Sergio P Acebron
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

2.  A chemical approach to myocardial protection and regeneration.

Authors:  Marco Piccoli; Federica Cirillo; Guido Tettamanti; Luigi Anastasia
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

Review 3.  Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.

Authors:  Yu Zhang; Wenlin Li; Timothy Laurent; Sheng Ding
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

Review 4.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

5.  Inhibition of androgen receptor and β-catenin activity in prostate cancer.

Authors:  Eugine Lee; Aviv Madar; Gregory David; Michael J Garabedian; Ramanuj Dasgupta; Susan K Logan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

Review 6.  Signaling networks in human pluripotent stem cells.

Authors:  Stephen Dalton
Journal:  Curr Opin Cell Biol       Date:  2012-10-22       Impact factor: 8.382

Review 7.  Progress in the reprogramming of somatic cells.

Authors:  Tianhua Ma; Min Xie; Timothy Laurent; Sheng Ding
Journal:  Circ Res       Date:  2013-02-01       Impact factor: 17.367

8.  Prognostic implication of SOX2 expression in small intestinal adenocarcinoma.

Authors:  Jeong Won Kim; Joon-Yong Chung; Kris Ylaya; Yoonho Park; Sun-Young Jun; Seung-Mo Hong; Stephen M Hewitt
Journal:  Virchows Arch       Date:  2020-10-25       Impact factor: 4.064

Review 9.  The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states.

Authors:  Nicola Festuccia; Rodrigo Osorno; Valerie Wilson; Ian Chambers
Journal:  Curr Opin Genet Dev       Date:  2013-08-07       Impact factor: 5.578

10.  Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells.

Authors:  Leslie A Kirby; Jason T Schott; Brenda L Noble; Daniel C Mendez; Paul S Caseley; Sarah C Peterson; Tyler J Routledge; Nilay V Patel
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.